Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Do the Side Effects of BRAF Inhibitors Mimic RASopathies?
Sfecci A, Dupuy A, Dinulescu M, Droitcourt C, Adamski H, Hadj-Rabia S, Odent S, Galibert MD, Boussemart L. Sfecci A, et al. Among authors: galibert md. J Invest Dermatol. 2017 Apr;137(4):805-809. doi: 10.1016/j.jid.2016.12.012. J Invest Dermatol. 2017. PMID: 28340684 Free article. Review.
In vivo and ex vivo UV-induced analysis of pigmentation gene expressions.
Corre S, Mekideche K, Adamski H, Mosser J, Watier E, Galibert MD. Corre S, et al. Among authors: galibert md. J Invest Dermatol. 2006 Apr;126(4):916-8. doi: 10.1038/sj.jid.5700190. J Invest Dermatol. 2006. PMID: 16470174 Free article. No abstract available.
ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.
Primot A, Mogha A, Corre S, Roberts K, Debbache J, Adamski H, Dreno B, Khammari A, Lesimple T, Mereau A, Goding CR, Galibert MD. Primot A, et al. Among authors: galibert md. Pigment Cell Melanoma Res. 2010 Feb;23(1):93-102. doi: 10.1111/j.1755-148X.2009.00652.x. Epub 2009 Nov 6. Pigment Cell Melanoma Res. 2010. PMID: 19895547
Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma.
Corre S, Tardif N, Mouchet N, Leclair HM, Boussemart L, Gautron A, Bachelot L, Perrot A, Soshilov A, Rogiers A, Rambow F, Dumontet E, Tarte K, Bessede A, Guillemin GJ, Marine JC, Denison MS, Gilot D, Galibert MD. Corre S, et al. Among authors: galibert md. Nat Commun. 2018 Nov 14;9(1):4775. doi: 10.1038/s41467-018-06951-2. Nat Commun. 2018. PMID: 30429474 Free PMC article.
Implementation of a molecular tumor board at a regional level to improve access to targeted therapy.
Bourien H, Lespagnol A, Campillo-Gimenez B, Felten-Vinot I, Metges JP, Corre R, Lesimple T, le Marechal C, Boussemart L, Kammerer-Jacquet SF, le Gall E, Denoual F, de Tayrac M, Galibert MD, Mosser J, Edeline J. Bourien H, et al. Among authors: galibert md. Int J Clin Oncol. 2020 Jul;25(7):1234-1241. doi: 10.1007/s10147-020-01661-6. Epub 2020 Mar 25. Int J Clin Oncol. 2020. PMID: 32215806 Free article.
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti-PD-1 Therapy.
Dousset L, Poizeau F, Robert C, Mansard S, Mortier L, Caumont C, Routier É, Dupuy A, Rouanet J, Battistella M, Greliak A, Cappellen D, Galibert MD, Allayous C, Lespagnol A, Gerard É, Kerneuzet I, Roy S, Dutriaux C, Merlio JP, Vergier B, Schrock AB, Lee J, Ali SM, Kammerer-Jacquet SF, Lebbé C, Beylot-Barry M, Boussemart L. Dousset L, et al. Among authors: galibert md. JCO Precis Oncol. 2021 Dec 16;5:PO.21.00084. doi: 10.1200/PO.21.00084. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34950838 Free PMC article.
73 results